These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 30515997)

  • 1. Impact of a borderless sample transport network for scaling up viral load monitoring: results of a geospatial optimization model for Zambia.
    Nichols BE; Girdwood SJ; Crompton T; Stewart-Isherwood L; Berrie L; Chimhamhiwa D; Moyo C; Kuehnle J; Stevens W; Rosen S;
    J Int AIDS Soc; 2018 Dec; 21(12):e25206. PubMed ID: 30515997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring viral load for the last mile: what will it cost?
    Nichols BE; Girdwood SJ; Crompton T; Stewart-Isherwood L; Berrie L; Chimhamhiwa D; Moyo C; Kuehnle J; Stevens W; Rosen S;
    J Int AIDS Soc; 2019 Sep; 22(9):e25337. PubMed ID: 31515967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing viral load testing access for the last mile: Geospatial cost model for point of care instrument placement.
    Girdwood SJ; Nichols BE; Moyo C; Crompton T; Chimhamhiwa D; Rosen S
    PLoS One; 2019; 14(8):e0221586. PubMed ID: 31449559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost and Impact of Dried Blood Spot Versus Plasma Separation Card for Scale-up of Viral Load Testing in Resource-limited Settings.
    Nichols BE; Girdwood SJ; Shibemba A; Sikota S; Gill CJ; Mwananyanda L; Noble L; Stewart-Isherwood L; Scott L; Carmona S; Rosen S; Stevens W
    Clin Infect Dis; 2020 Mar; 70(6):1014-1020. PubMed ID: 31321438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Returning HIV-1 viral load results to participant-selected health facilities in national Population-based HIV Impact Assessment (PHIA) household surveys in three sub-Saharan African Countries, 2015 to 2016.
    Saito S; Duong YT; Metz M; Lee K; Patel H; Sleeman K; Manjengwa J; Ogollah FM; Kasongo W; Mitchell R; Mugurungi O; Chimbwandira F; Moyo C; Maliwa V; Mtengo H; Nkumbula T; Ndongmo CB; Vere NS; Chipungu G; Parekh BS; Justman J; Voetsch AC
    J Int AIDS Soc; 2017 Nov; 20 Suppl 7(Suppl 7):. PubMed ID: 29171193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring of HIV viral load, CD4 cell count, and clinical assessment versus clinical monitoring alone for antiretroviral therapy in low-resource settings (Stratall ANRS 12110/ESTHER): a cost-effectiveness analysis.
    Boyer S; March L; Kouanfack C; Laborde-Balen G; Marino P; Aghokeng AF; Mpoudi-Ngole E; Koulla-Shiro S; Delaporte E; Carrieri MP; Spire B; Laurent C; Moatti JP;
    Lancet Infect Dis; 2013 Jul; 13(7):577-86. PubMed ID: 23602084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "After viral load testing, I get my results so I get to know which path my life is taking me": qualitative insights on routine centralized and point-of-care viral load testing in western Kenya from the Opt4Kids and Opt4Mamas studies.
    Qian SRW; Hassan SA; Scallon AJ; Oyaro P; Brown E; Wagude J; Mukui I; Kinywa E; Oluoch F; Odhiambo F; Oyaro B; Kingwara L; Yongo N; Karauki E; Gao J; Otieno L; John-Stewart GC; Abuogi LL; Patel RC
    BMC Health Serv Res; 2022 Dec; 22(1):1540. PubMed ID: 36528677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic and public health impact of decentralized HIV viral load testing: A modelling study in Kenya.
    de Necker M; de Beer JC; Stander MP; Connell CD; Mwai D
    PLoS One; 2019; 14(2):e0212972. PubMed ID: 30811510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of point-of-care viral load monitoring of antiretroviral therapy in resource-limited settings: mathematical modelling study.
    Estill J; Egger M; Blaser N; Vizcaya LS; Garone D; Wood R; Campbell J; Hallett TB; Keiser O;
    AIDS; 2013 Jun; 27(9):1483-92. PubMed ID: 23462219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The HIV Treatment Gap: Estimates of the Financial Resources Needed versus Available for Scale-Up of Antiretroviral Therapy in 97 Countries from 2015 to 2020.
    Dutta A; Barker C; Kallarakal A
    PLoS Med; 2015 Nov; 12(11):e1001907; discussion e1001907. PubMed ID: 26599990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Projecting the epidemiological effect, cost-effectiveness and transmission of HIV drug resistance in Vietnam associated with viral load monitoring strategies.
    Pham QD; Wilson DP; Nguyen TV; Do NT; Truong LX; Nguyen LT; Zhang L
    J Antimicrob Chemother; 2016 May; 71(5):1367-79. PubMed ID: 26869689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scaling up HIV viral load - lessons from the large-scale implementation of HIV early infant diagnosis and CD4 testing.
    Peter T; Zeh C; Katz Z; Elbireer A; Alemayehu B; Vojnov L; Costa A; Doi N; Jani I
    J Int AIDS Soc; 2017 Nov; 20 Suppl 7(Suppl 7):. PubMed ID: 29130601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using queueing models as a decision support tool in allocating point-of-care HIV viral load testing machines in Kisumu County, Kenya.
    Wang Y; Wagner AD; Liu S; Kingwara L; Oyaro P; Brown E; Karauki E; Yongo N; Bowen N; Kiiru J; Hassan S; Patel R
    Health Policy Plan; 2024 Jan; 39(1):44-55. PubMed ID: 37949109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Near Point-of-Care HIV Viral Load: Targeted Testing at Large Facilities.
    Ganesh P; Heller T; Chione B; Gumulira J; Gugsa S; Khan S; McGovern S; Nhlema A; Nkhoma L; Sacks JA; Trapence C; Tweya H; Ehrenkranz P; Phiri S
    J Acquir Immune Defic Syndr; 2021 Feb; 86(2):258-263. PubMed ID: 33136821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost analysis of centralized viral load testing for antiretroviral therapy monitoring in Nicaragua, a low-HIV prevalence, low-resource setting.
    Gerlach J; Sequeira M; Alvarado V; Cerpas C; Balmaseda A; Gonzalez A; de Los Santos T; Levin CE; Amador JJ; Domingo GJ
    J Int AIDS Soc; 2010 Nov; 13():43. PubMed ID: 21054866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal timing of viral load monitoring during pregnancy to predict viraemia at delivery in HIV-infected women initiating ART in South Africa: a simulation study.
    Lesosky M; Glass T; Mukonda E; Hsiao NY; Abrams EJ; Myer L
    J Int AIDS Soc; 2017 Nov; 20 Suppl 7(Suppl 7):. PubMed ID: 29171179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of different strategies to monitor adults on antiretroviral treatment: a combined analysis of three mathematical models.
    Keebler D; Revill P; Braithwaite S; Phillips A; Blaser N; Borquez A; Cambiano V; Ciaranello A; Estill J; Gray R; Hill A; Keiser O; Kessler J; Menzies NA; Nucifora KA; Vizcaya LS; Walker S; Welte A; Easterbrook P; Doherty M; Hirnschall G; Hallett TB
    Lancet Glob Health; 2014 Jan; 2(1):e35-43. PubMed ID: 25104633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of routine viral load monitoring in low- and middle-income countries: a systematic review.
    Barnabas RV; Revill P; Tan N; Phillips A
    J Int AIDS Soc; 2017 Nov; 20 Suppl 7(Suppl 7):. PubMed ID: 29171172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scale-up of Routine Viral Load Testing in Resource-Poor Settings: Current and Future Implementation Challenges.
    Roberts T; Cohn J; Bonner K; Hargreaves S
    Clin Infect Dis; 2016 Apr; 62(8):1043-8. PubMed ID: 26743094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A model for reduced HIV-1 viral load monitoring in resource-limited settings.
    Bryant L; Smith N; Keiser P
    J Int Assoc Provid AIDS Care; 2013; 12(1):67-71. PubMed ID: 22553318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.